Director/Senior Director, Business Development-Pharma Enterprise Sales
Ginkgo Bioworks, United States

Ginkgo Introduction
Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Ginkgo's platform enables partners to explore biological design space to discover and optimize their targets and processes in mammalian and microbial cells, with applications in cell, gene, RNA, microbiome and biologic therapeutic modalities.
Team Introduction
Pharma Business Development team focuses on exploring the applications of Ginkgo’s platform in the therapeutics and vaccines space, and building partnerships that reflect the business objectives. The business development team is an integral part of a cross-functional team, including Growth, technical, deal transaction, IP and legal teams, that drive collaborations from conception, through negotiation and, ultimately, to signing.
Specific Role Description
As a member of the Pharma Business Development team you are responsible for identifying areas and partners, in therapeutics and vaccine space, where our platform in collaborations with partners can address gaps in therapeutic modalities that enable our partners to address key unmet patient needs. You will be leading ownership of potential large enterprise account relationships, conceptualization of partnership frameworks, be responsible for shepherding deals to signing and be an ambassador of Ginkgo to the industry.
This role will be located at one of our European office locations or remote in Europe.


#LI-JH1Responsibilites

• Accountable for deal targets for a sub-vertical within the Pharma BD team
• Build and manage enterprise account strategy for multiple pharma partner and cultivate new research collaboration deal opportunities
• Identify new business opportunity areas(cross-modality or within a specific therapeutic modality), supported by market landscape assessments including key market needs and current participant capabilities across therapeutic modalities to shape Ginkgo’s partnership strategy
• Lead collaboration discussions and deal negotiations with potential partners in collaboration with broader commercial team
• Support and mentor BD team members on deal structuring and negotiations
• Travel, as necessary, for conferences or partner meetings-

Requirements

• Minimum Bachelor’s degree in engineering, and/or science; a Business degree will be a plus
• Minimum of 8 years depending on education and experience. Minimum of 12 years with Bachelors only
• Business development experience with deal sheet including research collaborations with pharma companies; preference for sell-side business development experience to large pharma organizations
• Learning agility to understand Ginkgo platform and pitch new applications in therapeutics and vaccine markets that could benefit industry
• Strong analytical skills, with an ability to develop fact-based business cases and informed opinions
• Passion for collaboration and significant experience in relationship-building, and leveraging and converting market knowledge and relationships into business opportunities
• Excellent communication skills, emotional intelligence and an ability to work across organizational boundaries
• Title/level will be based on your experience and education

This role will be located at one of our European office locations or remote in Europe.
To learn more about Ginkgo, check out some recent press: What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation (Endpoints News)Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)Ginkgo Raises $70 Million to Tackle Covid-19 Testing (Bloomberg)Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response (PR Newswire)How to Test Every American for COVID-19, Every Day (The Atlantic)The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)The engineering of living organisms could soon start changing everything (The Economist)Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)Ginkgo Bioworks Is Turning Human Cells into On-Demand Factories (WIRED)Can This Company Convince You to Love GMOs? (The Atlantic)
We also feel that it’s important to point out the obvious here there’s a serious lack of diversity in our industry, and that needs to change. Our goal is to help drive that change. Ginkgo is deeply committed to diversity, equity, and inclusion in all of its practices, especially when it comes to growing our